Wellington Management Group’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $234M | Sell |
5,372,061
-624,812
| -10% | -$27.3M | 0.04% | 323 |
|
|
2025
Q1 | $164M | Buy |
5,996,873
+689,547
| +13% | +$18.9M | 0.03% | 398 |
|
|
2024
Q4 | $214M | Buy |
5,307,326
+688,967
| +15% | +$27.7M | 0.04% | 354 |
|
|
2024
Q3 | $219M | Buy |
4,618,359
+308,954
| +7% | +$14.6M | 0.04% | 372 |
|
|
2024
Q2 | $129M | Buy |
4,309,405
+15,708
| +0.4% | +$469K | 0.02% | 480 |
|
|
2024
Q1 | $173M | Sell |
4,293,697
-521,861
| -11% | -$21M | 0.03% | 417 |
|
|
2023
Q4 | $123M | Sell |
4,815,558
-7,771
| -0.2% | -$198K | 0.02% | 519 |
|
|
2023
Q3 | $67M | Buy |
4,823,329
+646
| +0% | +$8.98K | 0.01% | 628 |
|
|
2023
Q2 | $111M | Buy |
4,822,683
+531,665
| +12% | +$12.2M | 0.02% | 524 |
|
|
2023
Q1 | $127M | Sell |
4,291,018
-300,071
| -7% | -$8.89M | 0.03% | 487 |
|
|
2022
Q4 | $115M | Buy |
4,591,089
+1,180,703
| +35% | +$29.5M | 0.02% | 497 |
|
|
2022
Q3 | $74.2M | Sell |
3,410,386
-1,624,554
| -32% | -$35.4M | 0.02% | 584 |
|
|
2022
Q2 | $99.1M | Buy |
5,034,940
+1,809,191
| +56% | +$35.6M | 0.02% | 540 |
|
|
2022
Q1 | $137M | Buy |
3,225,749
+530,935
| +20% | +$22.5M | 0.02% | 518 |
|
|
2021
Q4 | $171M | Buy |
2,694,814
+226,879
| +9% | +$14.4M | 0.03% | 487 |
|
|
2021
Q3 | $145M | Buy |
2,467,935
+1,639,994
| +198% | +$96.3M | 0.02% | 518 |
|
|
2021
Q2 | $40.2M | Buy |
827,941
+158,648
| +24% | +$7.69M | 0.01% | 895 |
|
|
2021
Q1 | $26M | Sell |
669,293
-1,021,286
| -60% | -$39.7M | ﹤0.01% | 1004 |
|
|
2020
Q4 | $104M | Sell |
1,690,579
-73,605
| -4% | -$4.53M | 0.02% | 580 |
|
|
2020
Q3 | $55.8M | Buy |
+1,764,184
| New | +$55.8M | 0.01% | 669 |
|